Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:103546.
doi: 10.1155/2015/103546. Epub 2016 Jan 10.

Interdisciplinary Medication Adherence Program: The Example of a University Community Pharmacy in Switzerland

Mélanie Lelubre  1 , Susan Kamal  1 , Noëllie Genre  2 , Jennifer Celio  1 , Séverine Gorgerat  2 , Denise Hugentobler Hampai  2 , Aline Bourdin  1 , Jerôme Berger  1 , Olivier Bugnon  1 , Marie Schneider  1
Affiliations

Interdisciplinary Medication Adherence Program: The Example of a University Community Pharmacy in Switzerland

Mélanie Lelubre et al. Biomed Res Int. 2015.

Abstract

The Community Pharmacy of the Department of Ambulatory Care and Community Medicine (Policlinique Médicale Universitaire, PMU), University of Lausanne, developed and implemented an interdisciplinary medication adherence program. The program aims to support and reinforce medication adherence through a multifactorial and interdisciplinary intervention. Motivational interviewing is combined with medication adherence electronic monitors (MEMS, Aardex MWV) and a report to patient, physician, nurse, and other pharmacists. This program has become a routine activity and was extended for use with all chronic diseases. From 2004 to 2014, there were 819 patient inclusions, and 268 patients were in follow-up in 2014. This paper aims to present the organization and program's context, statistical data, published research, and future perspectives.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Medication adherence program—organizational process. Note. EMs = electronic monitors of medication adherence.
Figure 2
Figure 2
Example: results of an electronic monitor—calendar and graph (from medAmigo [14]).
Figure 3
Figure 3
Fisher's model—Information-Motivation-Behavioral Skills model of adherence to antiretroviral treatment (adapted from Fisher et al. [16]). Note. HAART = highly active antiretroviral therapy.
Figure 4
Figure 4
Inclusion in the medication adherence program and stop from 2004 to 2014. Note. Patients who reentered the program after a gap of more than 1 year were considered to be new inclusions.
Figure 5
Figure 5
Number of medication adherence interviews delivered by pharmacists.
See this image and copyright information in PMC

References

    1. World Health Organization. Adherence to Long-Term Therapies—Evidence for Action. 2003. http://www.who.int/chp/knowledge/publications/adherence_report/en/
    1. Vrijens B., De Geest S., Hughes D. A., et al. A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology. 2012;73(5):691–705. doi: 10.1111/j.1365-2125.2012.04167.x. - DOI - PMC - PubMed
    1. Ortego C., Huedo-Medina T. B., Llorca J., et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS and Behavior. 2011;15(7):1381–1396. doi: 10.1007/s10461-011-9942-x. - DOI - PubMed
    1. Jeanneret L. A., Lüthi F., Schneider M. P., Troxler S., Bugnon O. Adhésion thérapeutique aux traitements oncologiques oraux et prise en charge interdisciplinaire. Revue Médicale Suisse. 2011;7(296):1154–1160. - PubMed
    1. Nieuwlaat R., Wilczynski W., Navarro T., et al. Interventions for enhancing medication adherence. The Cochrane Database of Systematic Reviews. 2014;11 doi: 10.1002/14651858.CD000011.pub4.CD000011 - DOI - PMC - PubMed

LinkOut - more resources